Showing results (381-390 of 447) with videos related to
Sort By:
Pageof 45
The New England Journal of Medicine|March 22, 2013
ERCC1 isoform expression and DNA repair in non-small-cell lung cancerLuc Friboulet, Ken André Olaussen, Jean-Pierre Pignon, et al.Lung Cancer (Amsterdam, Netherlands)|March 15, 2020
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226Rosalyn A Juergens, Desiree Hao, Peter M Ellis, et al.Cancer Cell|July 16, 2021
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activityJoel D Pearson, Katherine Huang, Marek Pacal, et al.Chest|May 5, 2016
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening StudyAlain Tremblay, Niloofar Taghizadeh, Annette M McWilliams, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLCCeline Mascaux, Triparna Sen, Montse Sanchez-Cespedes, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung CarcinomaHui Yu, Zhengming Chen, Karla V Ballman, et al.Biorxiv : the Preprint Server for Biology|May 13, 2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversionClaudia Gentile, William W Feng, Sean M Lenahan, et al.Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2018
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 ProjectMing Sound Tsao, Keith M Kerr, Mark Kockx, et al.Pageof 45